|
|
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
Firoozeh Sahebi
,
Simona Iacobelli
,
Giulia Sbianchi
,
Linda Koster
,
Didier Blaise
et al.
Journal articles
hal-02143580v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT
Thomas Heinicke
,
Myriam Labopin
,
Emmanuelle Polge
,
Dietger Niederwieser
,
Uwe Platzbecker
et al.
Journal articles
hal-03152845v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2
Lisa Riley
,
Matthew Heeney
,
Joëlle Rudinger-Thirion
,
Magali Frugier
,
Dean Campagna
et al.
Journal articles
hal-02118688v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion
Laurent Garderet
,
Dimitris Ziagkos
,
Anja van Biezen
,
Simona Lacobelli
,
Juergen Finke
et al.
Journal articles
hal-02143674v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Nicolaus Kröger
,
Giulia Sbianchi
,
Tiarlan Sirait
,
Christine Wolschke
,
Dietrich Beelen
et al.
Journal articles
hal-03628341v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Christoph Schmid
,
Myriam Labopin
,
Nicolaas Schaap
,
Hendrik Veelken
,
Arne Brecht
et al.
Journal articles
hal-03623692v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|